Typicality: | 0.382 |
Saliency: | 0.309 |
with low-grade lymphomas | 9 | other |
currently | 5 | temporal |
during clinical trials | 4 | temporal |
vaccine → be tested in → patient | 10 |
vaccine → be tested in → people | 9 |
vaccine → be tested on → people | 7 |
vaccine → be tested on → patient | 3 |
negative | neutral | positive |
0.183 | 0.688 | 0.129 |
Raw frequency | 29 |
Normalized frequency | 0.309 |
Modifier score | 0.500 |
Perplexity | 46.150 |